Mounjaro vs. Ozempic & Wegovy: What Head-to-Head SURMOUNT-5 Data Shows

Key Takeaways

In the direct head-to-head SURMOUNT-5 trial of 700+ adults without diabetes, tirzepatide achieved 20.2% mean weight loss at 72 weeks vs. 13.7% with semaglutide—a 47% greater relative reduction.
Tirzepatide targets both GIP and GLP-1 receptors, whereas Ozempic and Wegovy (both containing semaglutide) target GLP-1 receptors alone.
Ozempic is specifically indicated for type 2 diabetes, while Wegovy is the dedicated higher-dose semaglutide formulation indicated for chronic weight management.
Both medications are highly effective—if you are losing steadily and feeling great on semaglutide, there is rarely a clinical need to switch.

Inside the Landmark SURMOUNT-5 Head-to-Head Trial

For years, clinicians could only compare tirzepatide and semaglutide across separate trials. The 72-week SURMOUNT-5 randomized trial finally tested maximum-tolerated tirzepatide directly against semaglutide in adults with obesity or overweight and weight-related comorbidities (without diabetes):

Tirzepatide group: Lost an average of 20.2% of baseline body weight.
Semaglutide group: Lost an average of 13.7% of baseline body weight.
Relative advantage: Dual GIP/GLP-1 receptor activation produced 47% greater relative weight loss over 72 weeks, while semaglutide still delivered clinically transformative, double-digit weight reduction.

Side Effects, Licensing & When People Switch

Because both drugs activate GLP-1 receptors, digestive adjustment symptoms—nausea, constipation, diarrhea, heartburn, and mild fatigue—overlap closely, though individual tolerability varies (some patients report less abdominal cramping on tirzepatide, while others prefer semaglutide’s established cardiovascular outcome track record).

Clinicians consider switching only after optimizing nutrition, protein intake, and current titration tiers—typically when a patient hits a prolonged plateau at top dose or experiences persistent GI sensitivity on one molecule.

Finding the Best Fit for Your Metabolism

‘Better’ on average in a study doesn’t automatically mean necessary for every individual—consistency, side-effect comfort, medical history, and affordability all shape long-term success. Explore personalized semaglutide and tirzepatide programs at Amble Weight Loss.

Medical Editorial Review: Reviewed by the Amble Metabolic Team. This article is for educational purposes only and does not replace an individualized consultation with a licensed healthcare professional.

Related Clinical Guides

Women's Health & Hormones · 6 min readPost-Hair Transplant Care for Women: Recovery, Minoxidil & Hormone SafetyMost hair-transplant guides are written for men—yet female hair restoration carries distinct hormone rules, shock-loss prevention strategies, and long-term topical minoxidil protocols.Hair & Men's Health · 7 min readAdult Phimosis Explained: Causes, Symptoms & Topical Steroid TreatmentTight, painful, or non-retractable foreskin in adulthood is common and highly treatable—often without surgery. Learn how betamethasone 0.1% cream, gentle stretching, and glucose screening work.Hair & Men's Health · 6 min readDoes Finasteride Affect Muscle Growth, Strength, or Testosterone?Blocking DHT for hair loss won't shrink your gym progress. See what randomized clinical trials measuring lean body mass, grip strength, and serum testosterone actually show.

Medical weight losstailored to your biology

Clinician-guided GLP-1 and dual-hormone programs delivered discreetly.

Get started